An assessment of the role of Candida albicans antigen in atopic dermatitis

Journal of Dermatology

Volumn 26, Issue 5, 1999, Pages 282-287

  Morita, Eishin ^a   Hide, Michihiro ^b   Yoneya, Yasuko ^b   Kannbe, Masayuki ^b   Tanaka, Akira ^b   Yamamoto, Shoso ^b  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

Antifungal drugs; Atopic dermatitis; Candida albicans; Delayed type hypersensitivity; Immediate type hypersensitivity

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; FUNGUS ANTIGEN; IMMUNOGLOBULIN E; KETOCONAZOLE;

ADULT; ARTICLE; ATOPIC DERMATITIS; CANDIDA ALBICANS; CANDIDIASIS; CLINICAL ARTICLE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DRUG RESPONSE; FEMALE; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOGLOBULIN BLOOD LEVEL; MALE; SKIN MANIFESTATION;

EID: 0033043056     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.1999.tb03473.x     Document Type: Article

References (16)

1. Savolainen J, Koivikko A, Kalimo K, Nieminen E, Viander M: IgE, IgA and IgG antibodies and delayed skin response towards Candida albicans antigens in atopics with and without saprophytic growth, Clin Exp Allergy, 20: 549-554, 1990.
2. Savolainen J, Lammintausta K, Kalimo K, Viander M: Candida albicans and atopic dermatitis, Clin Exp Allergy, 23: 332-339, 1993.
3. Tanaka M, Aiba S, Matsumura N, et al: IgE-mediated hypersensitivity and contact sensitivity to multiple environmental allergens in atopic dermatitis, Arch Dermatol, 130: 1394-1401, 1994.
4. Tanaka M, Aiba S, Takahashi K, Tagami H: Reduced proliferative responses of peripheral blood mononuclear cells specifically to Candida albicans antigen in patients with atopic dermatitis - Comparison with their normal reactivity to bacterial superantigens, Arch Dermatol Res, 288: 495-499, 1996.
5. Matsumura N, Aiba S, Tanaka M, et al: Comparison of immune reactivity profiles against various environmental allergens between adult patients with atopic dermatitis and patients with allergic respiratory diseases, Acta Derm Venereol (Stockh), 77: 388-391, 1997.
6. Tagami H: Japanese Dermatological Association criteria for the diagnosis of atopic dermatitis, J Dermatol, 25: 696, 1998.
7. Rajka G, Langeland T: Grading of the severity of atopic dermatitis, Acta Derm Venereol (Stockh), 144: 13-14, 1989.
8. Sigurs N, Hattevig G, Kjellman B, Kjellman N-I M, Björksten B: Appearance of atopic disease in relation to serum IgE antibodies in children followed up from birth for 4 to 15 years, J Allergy Clin Immunol, 94: 757-763, 1994.
9. Uehara M: Atopic dermatitis and tuberculin reactivity, Arch Dermatol, 113: 1226-1228, 1977.
10. Shirakawa T, Enomoto T, Shimazu S, Hopkin JM: The inverse association between tuberculin and atopic disorder, Science, 275: 77-79, 1997.
11. Cooper KD: Atopic dermatitis: Recent trends in pathogenesis and therapy, J Invest Dermatol, 102: 128-137, 1994.
12. van der Heijden FL, Wierenga BA, Bos JD, Kapsenberg MK: High frequency of IL-4 producing CD4 + allergen-specific T lymphocytes in atopic dermatitis lesional skin, J Invest Dermatol, 97: 389-394, 1991.
13. Furue M, Ohtsuki M, Ogata F, Ishibashi Y: Responsiveness to interleukin 4 and interleukin 2 of peripheral blood mononuclear cells in atopic dermatitis, J Invest Dermatol, 96: 468-472, 1991.
14. Kitamura K, Suga C, Onuma S, et al: Efficacy of oral amphotericin B for refractory atopic dermatitis with specific IgE to Candida albicans and food allergens in sera, Allergol International, 46: 125-133, 1997.
15. Kroeger S, Neuber K, Gruseck E, Ring J, Abeck D: Pityrosporum ovate extracts increase interleukin-4, interleukin-10, and IgE synthesis in patients with atopic dermatitis, Acta Derm Venereol (Stockh), 75: 357-360, 1995.
16. Bäck O, Scheynius A, Johansson SGO: Ketoconazole in atopic dermatitis: Therapeutic response is correlated with decrease in serum IgE, Arch Dermatol Res, 287: 448-451, 1995.